NEW YORK, Oct. 24 /PRNewswire/ -- C.E. Unterberg, Towbin, a full-service investment bank focused on emerging growth companies, today announced that it will hold its annual Life Sciences Conference at the New York Palace Hotel on October 30-31st. Approximately 100 public and private companies will present to investors, including companies focused on Specialty Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics.
The format will be three concurrent tracks of company presentations which will address corporate growth strategies, product development updates, new product pipelines and industry trends. Following each presentation, there will be question and answer sessions, as well as scheduled one-on-one meetings available.
In addition, the two-day event will showcase three panels of industry experts moderated by our Senior Research Analysts covering the following topics:
1. Leukemia: Current and New Strategies for ALL and AML 2. Trends in the Treatment of Cystic Fibrosis; Could CF be the next PAH? 3. Atrial Fibrillation
“In a highly competitive marketplace, we remain as committed as ever to identifying and understanding opportunities throughout the healthcare sector. Our dynamic life sciences team has sought out the industry pioneers from both emerging and mature life science companies, maintaining a strong focus on what’s next,” commented Andy Arno, CEO. “This year’s Life Sciences Conference offers in-depth perspectives on the marketplace and the opportunity to meet the industry leaders of tomorrow,” Arno concluded.
Current List of Presenting Companies (subject to change): Company Name Ticker Aegerion Pharmaceuticals, Inc. Private Aeolus Pharmaceuticals Inc. AOLS.OB AEterna Zentaris Inc. AEZS Alfacell Corporation ACEL Alnylam Pharmaceuticals, Inc. ALNY Anesiva, Inc. ANSV Array BioPharma, Inc. ARRY ArthroCare Corporation ARTC AtriCure, Inc. ATRC BioCryst Pharmaceuticals, Inc. BCRX Biophan Technologies, Inc. BIPH BioSphere Medical, Inc. BSMD CAS Medical Systems, Inc. CASM Celldex Therapeutics, Inc. Private Chelsea Therapeutics International, Ltd. CHTP Chembio Diagnostics, Inc. CEMI Clinical Data Inc. CLDA Coley Pharmaceutical Group, Inc. COLY Compugen Ltd. CGEN Conceptus Inc. CPTS Cougar Biotechnology, Inc. Private Cyberkinetics Neurotechnology Systems, Inc. CYKN Cyclacel Pharmaceuticals, Inc. CYCC deCODE genetics, Inc. DCGN Delcath Systems, Inc. DCTH Devax, Inc. Private Diomed Holdings, Inc. DIO Encysive Pharmaceuticals Inc. ENCY Endocare, Inc. ENDO EP MedSystems, Inc. EPMD EPIX Pharmaceuticals, Inc. EPIX Generex Biotechnology Corporation GNBT Global Med Technologies, Inc. GLOB Greatbatch, Inc. GB GTC Biotherapeutics, Inc. GTCB Hana Biosciences, Inc. HNAB HeartScape Technologies, Inc. Private HeartWare Limited Private HearUSA, Inc. EAR Hologic, Inc. HOLX Immunomedics, Inc. IMMU Insmed Incorporated INSM Inspire Pharmaceuticals, Inc. ISPH Insulet Corporation Private InterMune, Inc. ITMN Inyx, Inc. IYXI IRIDEX Corporation IRIX Lev Pharmaceuticals, Inc. LEVP.OB Medarex, Inc. MEDX MedicalCV, Inc. MCVI Metabasis Therapeutics, Inc. MBRX MetaCure, Ltd. Private Monogram Biosciences, Inc. MGRM Nanogen, Inc. NGEN Neurologix, Inc. NRGX NeuroMetrix, Inc. NURO NMT Medical, Inc. NMTI Northwest Biotherapeutics, Inc. NWBT OMRIX Biopharmaceuticals, Inc. Private Opexa Therapeutics, Inc. OPXA Paracor Medical Inc. Private Peregrine Pharmaceuticals, Inc. PPHM Pharmion Corporation PHRM Pharmos Corp. PAS Poniard Pharmaceuticals, Inc. PARDP PreMD Inc. PME Progenics Pharmaceuticals, Inc. PGNX Protalex Inc. PRTX.OB Regeneration Technologies, Inc. RTIX Response Biomedical Corporation RPBIF Restore Medical, Inc. REST Rigel Pharmaceuticals, Inc. RIGL RITA Medical Systems, Inc. RITA Sanarus Medical, Inc. Private Sirna Therapeutics, Inc. RNAI Sirtris Pharmaceuticals, Inc. Private Spectrum Dynamics, Ltd. Private Stereotaxis Inc. STXS Sunesis Pharmaceuticals, Inc. SNSS Supergen Inc. SUPG Surface Logix Inc. Private SyntheMed, Inc. SYMD Tapestry Pharmaceuticals, Inc TPPH Targacept, Inc. TRGT Tercica, Inc. TRCA ViaCell, Inc. VIAC Vion Pharmaceuticals, Inc. VION VioQuest Pharmaceuticals, Inc. VQPH ViroPharma Incorporated VPHM YM BioSciences Inc. YMI Ziopharm Oncology Inc ZIOP
~ This conference is by invitation only. For more information, please contact your sales representative or see www.unterberg.com.
~ Media inquires should be directed to Marie@mkr-group.com, please include complete contact information and credentials.
About Unterberg: C.E. Unterberg, Towbin provides investment banking, research, and investment management services to emerging growth companies and investors in the technology, healthcare, and modern defense sectors.
INQUIRIES: Marie Dagresto or Charles Messman MKR Group (323) 468.2300 marie@mkr-group.com
C.E. Unterberg, Towbin
CONTACT: Marie Dagresto, marie@mkr-group.com, or Charles Messman, both ofMKR Group, +1-323-468-2300, for C.E. Unterberg, Towbin
Web site: http://www.unterberg.com//
